18/11/2015 : THERADIAG ANNOUNCES STRATEGIC AGREEMENT WITH MIRACA LIFE SCIENCES IN THE USA

Theradiag grants Miraca Life Sciences (MLS) know-how licensing agreement for therapeutic drug monitoring testsMLS to initiate tests offering throughout the United StatesCroissy-Beaubourg, 18 November 2015 — Theradiag (ISIN: FR0004197747, Ticker: ALTER) announced today a strategic licensing…

Continue Reading 18/11/2015 : THERADIAG ANNOUNCES STRATEGIC AGREEMENT WITH MIRACA LIFE SCIENCES IN THE USA

26/10/2015 : Theradiag receives Frost & Sullivan 2015 European Theranostics Product Leadership Award during Excellence in Best Practices Awards 2015 ceremony

Croissy-Beaubourg and Montpellier, October 26, 2015 – Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, announced today he received the Frost & Sullivan “2015 European Theranostics Product Leadership Award” during…

Continue Reading 26/10/2015 : Theradiag receives Frost & Sullivan 2015 European Theranostics Product Leadership Award during Excellence in Best Practices Awards 2015 ceremony

30/09/2015 : FINANCIAL AND OPERATIONAL RESULTS FOR THE FIRST HALF OF 2015

Strong increase in revenues and theranostics sales and signature of two partnership agreements with pharmaceutical companiesProduct sales rise to 3.4 M€Doubling of theranostic sales Signature of collaborative agreements with two pharmaceutical companiesCroissy-Beaubourg and Montpellier, September…

Continue Reading 30/09/2015 : FINANCIAL AND OPERATIONAL RESULTS FOR THE FIRST HALF OF 2015